Prevention Public Health Fund: Viral Hepatitis Prevention
Inactive
- Assistance listing
- 93.736
- Agency
-
Centers for Disease Control and Prevention
Department of Health and Human Services
- Grant awards
- 3 $292,203 in federal obligations
Program facts
- Also known as
- Viral Hepatitis Prevention, Screening, Linkage to Care and Education
- Assistance type
-
- Cooperative Agreement
- Eligible applicants
-
- Small business (less than 500 employees)
- Federally Recognized lndian Tribal Governments
- Public nonprofit institution/organization (includes institutions of higher education and hospitals)
- Minority group
- Quasi-public nonprofit institution/organization
- Local (includes State-designated lndian Tribes, excludes institutions of higher education and hospitals
- Other public institution/organization
- Sponsored organization
- Intrastate
- Other private institutions/organizations
- Profit organization
- Private nonprofit institution/organization (includes institutions of higher education and hospitals)
- Specialized group (e.g. health professionals, students, veterans)
- U.S. Territories and possessions (includes institutions of higher education and hospitals)
- Beneficiaries
-
- Individual/Family
Program details come from SAM.gov Assistance Listings. Updated . Grant award figures come from USAspending.gov.
About this program
The Centers for Disease Control and Prevention (CDC) under the Department of Health and Human Services operates the Prevention Public Health Fund: Viral Hepatitis Prevention program (CFDA 93.736), with the most recent grant award dated September 30, 2012—over fourteen years ago.
The program funds activities to reduce viral hepatitis transmission through increased awareness and testing among populations at risk for chronic HCV and HBV infection, linkage of infected individuals to clinical care, and capacity building within health departments and community health organizations. Funded activities include expanding HCV and HBV screening initiatives, developing and disseminating training and educational materials for healthcare professionals in both public and private sectors, and supporting state and local health departments in connecting infected persons to community health centers, clinics serving injection drug users, and other treatment settings. The program also supports monitoring, evaluation, and technical assistance.
Grant awards are predominantly Cooperative Agreements (67% of awards) with a smaller share of Project Grants (33%). The CDC is the sole funding source across the program. Combined federal dollars obligated total $292 thousand across three awards, all disbursed in the single 2012 cohort. Recent representative awards include a Cooperative Agreement funding HBV testing expansion and linkage to care targeting Sacramento's foreign-born Asian population ($100,000 federal share) and a Cooperative Agreement supporting early identification and linkage to care for hepatitis-infected persons ($192,500 federal share).
No recent grant opportunities or awards have been posted since September 2012. The program shows no documented activity over the past fourteen years and should be considered inactive for current business development purposes.
Objective and description
- Objective
Program activities under this funding will allow for CDC to partner with multiple organizations to benefit individuals by substantially reducing viral hepatitis transmission, identifing those that are chronically infected and linking infected individuals with treatment if appropriate. Specifically, the program activities may include but are not limited to: 1. Increasing the proportion of persons living with HCV and HBV who are aware of their infection and referred for prevention and clinical care services. 2. Expanding and improving efforts to develop and disseminate viral hepatitis training and educational materials targeting the public and private sector health care professionals to build capacity to assess, test and medically manage populations at risk for chronic HCV and HBV infection. 3. Supporting state and local health departments and other organizations in linking HCV infected persons to community health centers, clinics serving injection drug users, and other health organizations seeing individuals potentially infected with chronic viral hepatitis. 4. Additional support will be provided for program monitoring, evaluation, capacity building, and technical assistance.
Grant awards
Top recipients by federal obligations
| Rank | Recipient | Federal obligations | Share |
|---|---|---|---|
| 1 | Brightpoint Health | $192,500 | 66% |
| 2 | University Of California, Davis | $100,000 | 34% |
2 of 3 recipients listed here. See the rest on GovTribe.
Federal obligations by fiscal year
| Fiscal year | Federal obligations |
|---|---|
| FY2018 | -$297 |
| FY2012 | $6,699,982 |
Quick answers
What is Assistance Listing 93.736?
Assistance Listing 93.736 is Prevention Public Health Fund: Viral Hepatitis Prevention, a federal grant program run by Centers for Disease Control and Prevention (Department of Health and Human Services). It is inactive.
What is the CFDA number for Prevention Public Health Fund: Viral Hepatitis Prevention?
Its CFDA number is 93.736: Assistance Listing numbers were called CFDA numbers before 2018.
How much funding has Assistance Listing 93.736 awarded?
3 grant awards under 93.736 have obligated $292,203 in federal funds to 3 recipients.
Who receives the most funding from 93.736?
The recipients obligated the most under Prevention Public Health Fund: Viral Hepatitis Prevention are Brightpoint Health ($192,500) and University Of California, Davis ($100,000).
On GovTribe
See this program's full record
- Every grant award and opportunity under it
- Funding by recipient, agency and assistance type
- Alerts for new opportunities
- Ask GovTribe AI about this program